NCT05927415View on ClinicalTrials.gov

A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod

PHASE1CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

June 12, 2024

Study Completion Date

June 12, 2024

Conditions

Renal Impairment

Interventions

BIOLOGICAL

Efgartigimod IV

Intravenous infusion of efgartigimod

Trial Locations (2)

24105

CRS Clinical Research Services Kiel GmbH, Kiel

81241

APEX GmbH, Munich

Sponsors

Lead Sponsor

All Listed Sponsors

lead

argenx

INDUSTRY